Key Features: 1. Reviews current drugs in development and provides
practical advice to clinicians on the diagnosis and management of
fatty liver. 2. Proves attractive to primary care providers who are
on the frontline of managing patients with NAFLD, to
gastroenterologists and hepatologists who would benefit from
updated data on how to risk stratify patients and identify those
who will be eligible for pharmacologic treatment, and other
specialists such as cardiologists, endocrinologists, and
nephrologists will find this book to be a useful reference on the
extrahepatic manifestations of NAFLD. 3. Focuses on extra-hepatic
manifestations and new insights on the mechanistic drivers of the
disease.
General
| Imprint: |
Taylor & Francis
|
| Country of origin: |
United Kingdom |
| Release date: |
September 2023 |
| First published: |
2024 |
| Editors: |
Naim Alkhouri
• Stephen A. Harrison
|
| Dimensions: |
280 x 210mm (L x W) |
| Pages: |
242 |
| ISBN-13: |
978-1-03-247948-4 |
| Categories: |
Books
|
| LSN: |
1-03-247948-5 |
| Barcode: |
9781032479484 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
